nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Alkylating Activity—Busulfan—hematologic cancer	0.136	0.151	CiPCiCtD
Altretamine—Alkylating Activity—Procarbazine—hematologic cancer	0.103	0.114	CiPCiCtD
Altretamine—Alkylating Activity—Lomustine—hematologic cancer	0.103	0.114	CiPCiCtD
Altretamine—Alkylating Activity—Mechlorethamine—hematologic cancer	0.103	0.114	CiPCiCtD
Altretamine—Alkylating Activity—Ifosfamide—hematologic cancer	0.0878	0.0973	CiPCiCtD
Altretamine—Alkylating Activity—Thiotepa—hematologic cancer	0.0782	0.0867	CiPCiCtD
Altretamine—Alkylating Activity—Melphalan—hematologic cancer	0.0782	0.0867	CiPCiCtD
Altretamine—Alkylating Activity—Chlorambucil—hematologic cancer	0.0782	0.0867	CiPCiCtD
Altretamine—Alkylating Activity—Carmustine—hematologic cancer	0.0715	0.0793	CiPCiCtD
Altretamine—Alkylating Activity—Dacarbazine—hematologic cancer	0.0625	0.0693	CiPCiCtD
Altretamine—Anaemia—Mitoxantrone—hematologic cancer	6.66e-05	0.000682	CcSEcCtD
Altretamine—Anaemia—Irinotecan—hematologic cancer	6.66e-05	0.000682	CcSEcCtD
Altretamine—Convulsion—Alitretinoin—hematologic cancer	6.65e-05	0.000681	CcSEcCtD
Altretamine—Vertigo—Vincristine—hematologic cancer	6.65e-05	0.000681	CcSEcCtD
Altretamine—Vomiting—Busulfan—hematologic cancer	6.62e-05	0.000679	CcSEcCtD
Altretamine—Leukopenia—Vincristine—hematologic cancer	6.62e-05	0.000678	CcSEcCtD
Altretamine—Convulsion—Ifosfamide—hematologic cancer	6.57e-05	0.000674	CcSEcCtD
Altretamine—Asthenia—Nilotinib—hematologic cancer	6.57e-05	0.000673	CcSEcCtD
Altretamine—Dizziness—Bexarotene—hematologic cancer	6.55e-05	0.000671	CcSEcCtD
Altretamine—Dizziness—Dasatinib—hematologic cancer	6.55e-05	0.000671	CcSEcCtD
Altretamine—Asthenia—Imatinib—hematologic cancer	6.53e-05	0.000669	CcSEcCtD
Altretamine—Anorexia—Thiotepa—hematologic cancer	6.49e-05	0.000665	CcSEcCtD
Altretamine—Anaemia—Gemcitabine—hematologic cancer	6.49e-05	0.000665	CcSEcCtD
Altretamine—Vertigo—Irinotecan—hematologic cancer	6.47e-05	0.000663	CcSEcCtD
Altretamine—Leukopenia—Irinotecan—hematologic cancer	6.45e-05	0.000661	CcSEcCtD
Altretamine—Leukopenia—Mitoxantrone—hematologic cancer	6.45e-05	0.000661	CcSEcCtD
Altretamine—Thrombocytopenia—Thalidomide—hematologic cancer	6.45e-05	0.000661	CcSEcCtD
Altretamine—Neoplasm—Doxorubicin—hematologic cancer	6.43e-05	0.000659	CcSEcCtD
Altretamine—Vomiting—Procarbazine—hematologic cancer	6.43e-05	0.000659	CcSEcCtD
Altretamine—Asthenia—Cladribine—hematologic cancer	6.42e-05	0.000658	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Epirubicin—hematologic cancer	6.41e-05	0.000657	CcSEcCtD
Altretamine—Convulsion—Vincristine—hematologic cancer	6.41e-05	0.000657	CcSEcCtD
Altretamine—Decreased appetite—Bortezomib—hematologic cancer	6.35e-05	0.00065	CcSEcCtD
Altretamine—Vomiting—Bexarotene—hematologic cancer	6.3e-05	0.000646	CcSEcCtD
Altretamine—Vomiting—Dasatinib—hematologic cancer	6.3e-05	0.000646	CcSEcCtD
Altretamine—Decreased appetite—Bleomycin—hematologic cancer	6.3e-05	0.000645	CcSEcCtD
Altretamine—Fatigue—Bortezomib—hematologic cancer	6.29e-05	0.000645	CcSEcCtD
Altretamine—Vomiting—Fludarabine—hematologic cancer	6.28e-05	0.000644	CcSEcCtD
Altretamine—Leukopenia—Gemcitabine—hematologic cancer	6.28e-05	0.000644	CcSEcCtD
Altretamine—Anorexia—Thalidomide—hematologic cancer	6.28e-05	0.000643	CcSEcCtD
Altretamine—Convulsion—Mitoxantrone—hematologic cancer	6.24e-05	0.00064	CcSEcCtD
Altretamine—Decreased appetite—Vinorelbine—hematologic cancer	6.2e-05	0.000635	CcSEcCtD
Altretamine—Thrombocytopenia—Carmustine—hematologic cancer	6.19e-05	0.000634	CcSEcCtD
Altretamine—Nausea—Busulfan—hematologic cancer	6.19e-05	0.000634	CcSEcCtD
Altretamine—Neuropathy peripheral—Betamethasone—hematologic cancer	6.19e-05	0.000634	CcSEcCtD
Altretamine—Neuropathy peripheral—Dexamethasone—hematologic cancer	6.19e-05	0.000634	CcSEcCtD
Altretamine—Asthenia—Vinblastine—hematologic cancer	6.15e-05	0.000631	CcSEcCtD
Altretamine—Fatigue—Vinorelbine—hematologic cancer	6.15e-05	0.00063	CcSEcCtD
Altretamine—Thrombocytopenia—Alitretinoin—hematologic cancer	6.13e-05	0.000629	CcSEcCtD
Altretamine—Thrombocytopenia—Ifosfamide—hematologic cancer	6.06e-05	0.000621	CcSEcCtD
Altretamine—Dizziness—Nilotinib—hematologic cancer	6.05e-05	0.00062	CcSEcCtD
Altretamine—Anaemia—Cisplatin—hematologic cancer	6.05e-05	0.000619	CcSEcCtD
Altretamine—Anorexia—Carmustine—hematologic cancer	6.03e-05	0.000618	CcSEcCtD
Altretamine—Dizziness—Imatinib—hematologic cancer	6.02e-05	0.000617	CcSEcCtD
Altretamine—Nausea—Procarbazine—hematologic cancer	6e-05	0.000615	CcSEcCtD
Altretamine—Anorexia—Alitretinoin—hematologic cancer	5.97e-05	0.000612	CcSEcCtD
Altretamine—Vomiting—Chlorambucil—hematologic cancer	5.95e-05	0.00061	CcSEcCtD
Altretamine—Blood alkaline phosphatase increased—Doxorubicin—hematologic cancer	5.93e-05	0.000608	CcSEcCtD
Altretamine—Decreased appetite—Thiotepa—hematologic cancer	5.92e-05	0.000606	CcSEcCtD
Altretamine—Dizziness—Cladribine—hematologic cancer	5.91e-05	0.000606	CcSEcCtD
Altretamine—Thrombocytopenia—Vincristine—hematologic cancer	5.91e-05	0.000606	CcSEcCtD
Altretamine—Anorexia—Ifosfamide—hematologic cancer	5.9e-05	0.000605	CcSEcCtD
Altretamine—Nausea—Dasatinib—hematologic cancer	5.89e-05	0.000603	CcSEcCtD
Altretamine—Nausea—Bexarotene—hematologic cancer	5.89e-05	0.000603	CcSEcCtD
Altretamine—Fatigue—Thiotepa—hematologic cancer	5.87e-05	0.000601	CcSEcCtD
Altretamine—Nausea—Fludarabine—hematologic cancer	5.87e-05	0.000601	CcSEcCtD
Altretamine—Leukopenia—Cisplatin—hematologic cancer	5.85e-05	0.0006	CcSEcCtD
Altretamine—Asthenia—Melphalan—hematologic cancer	5.85e-05	0.0006	CcSEcCtD
Altretamine—Vomiting—Nilotinib—hematologic cancer	5.82e-05	0.000596	CcSEcCtD
Altretamine—Vomiting—Imatinib—hematologic cancer	5.79e-05	0.000593	CcSEcCtD
Altretamine—Thrombocytopenia—Irinotecan—hematologic cancer	5.76e-05	0.00059	CcSEcCtD
Altretamine—Thrombocytopenia—Mitoxantrone—hematologic cancer	5.76e-05	0.00059	CcSEcCtD
Altretamine—Anorexia—Vincristine—hematologic cancer	5.75e-05	0.00059	CcSEcCtD
Altretamine—Decreased appetite—Thalidomide—hematologic cancer	5.72e-05	0.000586	CcSEcCtD
Altretamine—Asthenia—Lenalidomide—hematologic cancer	5.69e-05	0.000583	CcSEcCtD
Altretamine—Vomiting—Cladribine—hematologic cancer	5.69e-05	0.000583	CcSEcCtD
Altretamine—Fatigue—Thalidomide—hematologic cancer	5.68e-05	0.000582	CcSEcCtD
Altretamine—Dizziness—Vinblastine—hematologic cancer	5.67e-05	0.000581	CcSEcCtD
Altretamine—Convulsion—Cisplatin—hematologic cancer	5.67e-05	0.000581	CcSEcCtD
Altretamine—Asthenia—Hydroxyurea—hematologic cancer	5.61e-05	0.000575	CcSEcCtD
Altretamine—Thrombocytopenia—Gemcitabine—hematologic cancer	5.61e-05	0.000575	CcSEcCtD
Altretamine—Anorexia—Mitoxantrone—hematologic cancer	5.6e-05	0.000574	CcSEcCtD
Altretamine—Anorexia—Irinotecan—hematologic cancer	5.6e-05	0.000574	CcSEcCtD
Altretamine—Ataxia—Methotrexate—hematologic cancer	5.6e-05	0.000574	CcSEcCtD
Altretamine—Nausea—Chlorambucil—hematologic cancer	5.56e-05	0.00057	CcSEcCtD
Altretamine—Anaemia—Etoposide—hematologic cancer	5.54e-05	0.000567	CcSEcCtD
Altretamine—Decreased appetite—Carmustine—hematologic cancer	5.5e-05	0.000563	CcSEcCtD
Altretamine—Anorexia—Gemcitabine—hematologic cancer	5.46e-05	0.000559	CcSEcCtD
Altretamine—Vomiting—Vinblastine—hematologic cancer	5.45e-05	0.000559	CcSEcCtD
Altretamine—Decreased appetite—Alitretinoin—hematologic cancer	5.45e-05	0.000558	CcSEcCtD
Altretamine—Nausea—Nilotinib—hematologic cancer	5.44e-05	0.000557	CcSEcCtD
Altretamine—Nausea—Imatinib—hematologic cancer	5.41e-05	0.000554	CcSEcCtD
Altretamine—Fatigue—Alitretinoin—hematologic cancer	5.4e-05	0.000553	CcSEcCtD
Altretamine—Neuropathy peripheral—Prednisone—hematologic cancer	5.39e-05	0.000552	CcSEcCtD
Altretamine—Vertigo—Etoposide—hematologic cancer	5.38e-05	0.000552	CcSEcCtD
Altretamine—Decreased appetite—Ifosfamide—hematologic cancer	5.38e-05	0.000552	CcSEcCtD
Altretamine—Leukopenia—Etoposide—hematologic cancer	5.36e-05	0.00055	CcSEcCtD
Altretamine—Fatigue—Ifosfamide—hematologic cancer	5.34e-05	0.000547	CcSEcCtD
Altretamine—Nausea—Cladribine—hematologic cancer	5.31e-05	0.000544	CcSEcCtD
Altretamine—Vertigo—Prednisolone—hematologic cancer	5.31e-05	0.000544	CcSEcCtD
Altretamine—Decreased appetite—Vincristine—hematologic cancer	5.25e-05	0.000538	CcSEcCtD
Altretamine—Dizziness—Lenalidomide—hematologic cancer	5.25e-05	0.000538	CcSEcCtD
Altretamine—Ataxia—Epirubicin—hematologic cancer	5.24e-05	0.000537	CcSEcCtD
Altretamine—Asthenia—Bortezomib—hematologic cancer	5.24e-05	0.000537	CcSEcCtD
Altretamine—Thrombocytopenia—Cisplatin—hematologic cancer	5.23e-05	0.000536	CcSEcCtD
Altretamine—Fatigue—Vincristine—hematologic cancer	5.2e-05	0.000533	CcSEcCtD
Altretamine—Asthenia—Bleomycin—hematologic cancer	5.2e-05	0.000533	CcSEcCtD
Altretamine—Convulsion—Etoposide—hematologic cancer	5.19e-05	0.000532	CcSEcCtD
Altretamine—Vomiting—Melphalan—hematologic cancer	5.19e-05	0.000532	CcSEcCtD
Altretamine—Dizziness—Hydroxyurea—hematologic cancer	5.17e-05	0.00053	CcSEcCtD
Altretamine—Convulsion—Prednisolone—hematologic cancer	5.12e-05	0.000525	CcSEcCtD
Altretamine—Asthenia—Vinorelbine—hematologic cancer	5.11e-05	0.000524	CcSEcCtD
Altretamine—Decreased appetite—Mitoxantrone—hematologic cancer	5.11e-05	0.000524	CcSEcCtD
Altretamine—Decreased appetite—Irinotecan—hematologic cancer	5.11e-05	0.000524	CcSEcCtD
Altretamine—Nausea—Vinblastine—hematologic cancer	5.1e-05	0.000522	CcSEcCtD
Altretamine—Anorexia—Cisplatin—hematologic cancer	5.09e-05	0.000521	CcSEcCtD
Altretamine—Fatigue—Mitoxantrone—hematologic cancer	5.07e-05	0.000519	CcSEcCtD
Altretamine—Fatigue—Irinotecan—hematologic cancer	5.07e-05	0.000519	CcSEcCtD
Altretamine—Vomiting—Lenalidomide—hematologic cancer	5.04e-05	0.000517	CcSEcCtD
Altretamine—Decreased appetite—Gemcitabine—hematologic cancer	4.98e-05	0.00051	CcSEcCtD
Altretamine—Vomiting—Hydroxyurea—hematologic cancer	4.97e-05	0.00051	CcSEcCtD
Altretamine—Fatigue—Gemcitabine—hematologic cancer	4.94e-05	0.000506	CcSEcCtD
Altretamine—Pancytopenia—Methotrexate—hematologic cancer	4.89e-05	0.000501	CcSEcCtD
Altretamine—Asthenia—Thiotepa—hematologic cancer	4.88e-05	0.0005	CcSEcCtD
Altretamine—Vertigo—Triamcinolone—hematologic cancer	4.88e-05	0.0005	CcSEcCtD
Altretamine—Ataxia—Doxorubicin—hematologic cancer	4.85e-05	0.000497	CcSEcCtD
Altretamine—Nausea—Melphalan—hematologic cancer	4.85e-05	0.000497	CcSEcCtD
Altretamine—Dizziness—Bortezomib—hematologic cancer	4.83e-05	0.000495	CcSEcCtD
Altretamine—Thrombocytopenia—Etoposide—hematologic cancer	4.79e-05	0.000491	CcSEcCtD
Altretamine—Asthenia—Thalidomide—hematologic cancer	4.72e-05	0.000484	CcSEcCtD
Altretamine—Dizziness—Vinorelbine—hematologic cancer	4.71e-05	0.000483	CcSEcCtD
Altretamine—Nausea—Lenalidomide—hematologic cancer	4.71e-05	0.000483	CcSEcCtD
Altretamine—Convulsion—Triamcinolone—hematologic cancer	4.71e-05	0.000482	CcSEcCtD
Altretamine—Anorexia—Etoposide—hematologic cancer	4.66e-05	0.000478	CcSEcCtD
Altretamine—Nausea—Hydroxyurea—hematologic cancer	4.65e-05	0.000476	CcSEcCtD
Altretamine—Vomiting—Bortezomib—hematologic cancer	4.64e-05	0.000476	CcSEcCtD
Altretamine—Decreased appetite—Cisplatin—hematologic cancer	4.64e-05	0.000475	CcSEcCtD
Altretamine—Vomiting—Bleomycin—hematologic cancer	4.61e-05	0.000472	CcSEcCtD
Altretamine—Pancytopenia—Epirubicin—hematologic cancer	4.58e-05	0.000469	CcSEcCtD
Altretamine—Asthenia—Carmustine—hematologic cancer	4.54e-05	0.000465	CcSEcCtD
Altretamine—Vomiting—Vinorelbine—hematologic cancer	4.53e-05	0.000464	CcSEcCtD
Altretamine—Dizziness—Thiotepa—hematologic cancer	4.5e-05	0.000461	CcSEcCtD
Altretamine—Asthenia—Alitretinoin—hematologic cancer	4.49e-05	0.000461	CcSEcCtD
Altretamine—Asthenia—Ifosfamide—hematologic cancer	4.44e-05	0.000455	CcSEcCtD
Altretamine—Vertigo—Dexamethasone—hematologic cancer	4.43e-05	0.000454	CcSEcCtD
Altretamine—Vertigo—Betamethasone—hematologic cancer	4.43e-05	0.000454	CcSEcCtD
Altretamine—Dizziness—Thalidomide—hematologic cancer	4.35e-05	0.000446	CcSEcCtD
Altretamine—Nausea—Bortezomib—hematologic cancer	4.34e-05	0.000444	CcSEcCtD
Altretamine—Asthenia—Vincristine—hematologic cancer	4.33e-05	0.000444	CcSEcCtD
Altretamine—Vomiting—Thiotepa—hematologic cancer	4.33e-05	0.000444	CcSEcCtD
Altretamine—Nausea—Bleomycin—hematologic cancer	4.3e-05	0.000441	CcSEcCtD
Altretamine—Convulsion—Betamethasone—hematologic cancer	4.27e-05	0.000438	CcSEcCtD
Altretamine—Convulsion—Dexamethasone—hematologic cancer	4.27e-05	0.000438	CcSEcCtD
Altretamine—Decreased appetite—Etoposide—hematologic cancer	4.25e-05	0.000436	CcSEcCtD
Altretamine—Pancytopenia—Doxorubicin—hematologic cancer	4.24e-05	0.000434	CcSEcCtD
Altretamine—Nausea—Vinorelbine—hematologic cancer	4.23e-05	0.000434	CcSEcCtD
Altretamine—Asthenia—Mitoxantrone—hematologic cancer	4.22e-05	0.000432	CcSEcCtD
Altretamine—Asthenia—Irinotecan—hematologic cancer	4.22e-05	0.000432	CcSEcCtD
Altretamine—Fatigue—Etoposide—hematologic cancer	4.22e-05	0.000432	CcSEcCtD
Altretamine—Neuropathy peripheral—Epirubicin—hematologic cancer	4.21e-05	0.000432	CcSEcCtD
Altretamine—Vomiting—Thalidomide—hematologic cancer	4.19e-05	0.000429	CcSEcCtD
Altretamine—Dizziness—Carmustine—hematologic cancer	4.18e-05	0.000428	CcSEcCtD
Altretamine—Dizziness—Alitretinoin—hematologic cancer	4.14e-05	0.000424	CcSEcCtD
Altretamine—Asthenia—Gemcitabine—hematologic cancer	4.11e-05	0.000421	CcSEcCtD
Altretamine—Dizziness—Ifosfamide—hematologic cancer	4.09e-05	0.00042	CcSEcCtD
Altretamine—Nausea—Thiotepa—hematologic cancer	4.04e-05	0.000414	CcSEcCtD
Altretamine—Vomiting—Carmustine—hematologic cancer	4.02e-05	0.000412	CcSEcCtD
Altretamine—Dizziness—Vincristine—hematologic cancer	3.99e-05	0.000409	CcSEcCtD
Altretamine—Vomiting—Alitretinoin—hematologic cancer	3.98e-05	0.000408	CcSEcCtD
Altretamine—Anaemia—Prednisone—hematologic cancer	3.97e-05	0.000407	CcSEcCtD
Altretamine—Thrombocytopenia—Betamethasone—hematologic cancer	3.94e-05	0.000404	CcSEcCtD
Altretamine—Thrombocytopenia—Dexamethasone—hematologic cancer	3.94e-05	0.000404	CcSEcCtD
Altretamine—Vomiting—Ifosfamide—hematologic cancer	3.94e-05	0.000403	CcSEcCtD
Altretamine—Nausea—Thalidomide—hematologic cancer	3.91e-05	0.000401	CcSEcCtD
Altretamine—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.9e-05	0.000399	CcSEcCtD
Altretamine—Dizziness—Irinotecan—hematologic cancer	3.89e-05	0.000398	CcSEcCtD
Altretamine—Vertigo—Prednisone—hematologic cancer	3.86e-05	0.000395	CcSEcCtD
Altretamine—Vomiting—Vincristine—hematologic cancer	3.84e-05	0.000393	CcSEcCtD
Altretamine—Anorexia—Betamethasone—hematologic cancer	3.84e-05	0.000393	CcSEcCtD
Altretamine—Anorexia—Dexamethasone—hematologic cancer	3.84e-05	0.000393	CcSEcCtD
Altretamine—Asthenia—Cisplatin—hematologic cancer	3.83e-05	0.000392	CcSEcCtD
Altretamine—Fatigue—Triamcinolone—hematologic cancer	3.82e-05	0.000392	CcSEcCtD
Altretamine—Nausea—Carmustine—hematologic cancer	3.76e-05	0.000385	CcSEcCtD
Altretamine—Vomiting—Mitoxantrone—hematologic cancer	3.74e-05	0.000383	CcSEcCtD
Altretamine—Vomiting—Irinotecan—hematologic cancer	3.74e-05	0.000383	CcSEcCtD
Altretamine—Nausea—Alitretinoin—hematologic cancer	3.72e-05	0.000381	CcSEcCtD
Altretamine—Convulsion—Prednisone—hematologic cancer	3.72e-05	0.000381	CcSEcCtD
Altretamine—Nausea—Ifosfamide—hematologic cancer	3.68e-05	0.000377	CcSEcCtD
Altretamine—Vomiting—Gemcitabine—hematologic cancer	3.64e-05	0.000373	CcSEcCtD
Altretamine—Nausea—Vincristine—hematologic cancer	3.59e-05	0.000367	CcSEcCtD
Altretamine—Asthenia—Etoposide—hematologic cancer	3.51e-05	0.00036	CcSEcCtD
Altretamine—Decreased appetite—Betamethasone—hematologic cancer	3.5e-05	0.000358	CcSEcCtD
Altretamine—Decreased appetite—Dexamethasone—hematologic cancer	3.5e-05	0.000358	CcSEcCtD
Altretamine—Nausea—Irinotecan—hematologic cancer	3.49e-05	0.000358	CcSEcCtD
Altretamine—Nausea—Mitoxantrone—hematologic cancer	3.49e-05	0.000358	CcSEcCtD
Altretamine—Fatigue—Betamethasone—hematologic cancer	3.47e-05	0.000356	CcSEcCtD
Altretamine—Fatigue—Dexamethasone—hematologic cancer	3.47e-05	0.000356	CcSEcCtD
Altretamine—Nausea—Gemcitabine—hematologic cancer	3.4e-05	0.000349	CcSEcCtD
Altretamine—Vomiting—Cisplatin—hematologic cancer	3.39e-05	0.000348	CcSEcCtD
Altretamine—Anorexia—Prednisone—hematologic cancer	3.34e-05	0.000342	CcSEcCtD
Altretamine—Anaemia—Methotrexate—hematologic cancer	3.32e-05	0.00034	CcSEcCtD
Altretamine—Dizziness—Etoposide—hematologic cancer	3.23e-05	0.000331	CcSEcCtD
Altretamine—Vertigo—Methotrexate—hematologic cancer	3.22e-05	0.00033	CcSEcCtD
Altretamine—Leukopenia—Methotrexate—hematologic cancer	3.21e-05	0.000329	CcSEcCtD
Altretamine—Dizziness—Prednisolone—hematologic cancer	3.19e-05	0.000327	CcSEcCtD
Altretamine—Asthenia—Triamcinolone—hematologic cancer	3.18e-05	0.000326	CcSEcCtD
Altretamine—Nausea—Cisplatin—hematologic cancer	3.17e-05	0.000325	CcSEcCtD
Altretamine—Convulsion—Methotrexate—hematologic cancer	3.11e-05	0.000319	CcSEcCtD
Altretamine—Vomiting—Etoposide—hematologic cancer	3.11e-05	0.000319	CcSEcCtD
Altretamine—Anaemia—Epirubicin—hematologic cancer	3.1e-05	0.000318	CcSEcCtD
Altretamine—Decreased appetite—Prednisone—hematologic cancer	3.05e-05	0.000312	CcSEcCtD
Altretamine—Fatigue—Prednisone—hematologic cancer	3.02e-05	0.00031	CcSEcCtD
Altretamine—Vertigo—Epirubicin—hematologic cancer	3.02e-05	0.000309	CcSEcCtD
Altretamine—Leukopenia—Epirubicin—hematologic cancer	3.01e-05	0.000308	CcSEcCtD
Altretamine—Dizziness—Triamcinolone—hematologic cancer	2.93e-05	0.000301	CcSEcCtD
Altretamine—Convulsion—Epirubicin—hematologic cancer	2.91e-05	0.000298	CcSEcCtD
Altretamine—Nausea—Etoposide—hematologic cancer	2.9e-05	0.000298	CcSEcCtD
Altretamine—Asthenia—Dexamethasone—hematologic cancer	2.89e-05	0.000296	CcSEcCtD
Altretamine—Asthenia—Betamethasone—hematologic cancer	2.89e-05	0.000296	CcSEcCtD
Altretamine—Anaemia—Doxorubicin—hematologic cancer	2.87e-05	0.000294	CcSEcCtD
Altretamine—Thrombocytopenia—Methotrexate—hematologic cancer	2.87e-05	0.000294	CcSEcCtD
Altretamine—Nausea—Prednisolone—hematologic cancer	2.86e-05	0.000294	CcSEcCtD
Altretamine—Vomiting—Triamcinolone—hematologic cancer	2.82e-05	0.000289	CcSEcCtD
Altretamine—Vertigo—Doxorubicin—hematologic cancer	2.79e-05	0.000286	CcSEcCtD
Altretamine—Anorexia—Methotrexate—hematologic cancer	2.79e-05	0.000286	CcSEcCtD
Altretamine—Leukopenia—Doxorubicin—hematologic cancer	2.78e-05	0.000285	CcSEcCtD
Altretamine—Convulsion—Doxorubicin—hematologic cancer	2.69e-05	0.000276	CcSEcCtD
Altretamine—Thrombocytopenia—Epirubicin—hematologic cancer	2.68e-05	0.000275	CcSEcCtD
Altretamine—Dizziness—Betamethasone—hematologic cancer	2.66e-05	0.000273	CcSEcCtD
Altretamine—Dizziness—Dexamethasone—hematologic cancer	2.66e-05	0.000273	CcSEcCtD
Altretamine—Nausea—Triamcinolone—hematologic cancer	2.63e-05	0.00027	CcSEcCtD
Altretamine—Anorexia—Epirubicin—hematologic cancer	2.61e-05	0.000268	CcSEcCtD
Altretamine—Vomiting—Dexamethasone—hematologic cancer	2.56e-05	0.000262	CcSEcCtD
Altretamine—Vomiting—Betamethasone—hematologic cancer	2.56e-05	0.000262	CcSEcCtD
Altretamine—Decreased appetite—Methotrexate—hematologic cancer	2.55e-05	0.000261	CcSEcCtD
Altretamine—Fatigue—Methotrexate—hematologic cancer	2.53e-05	0.000259	CcSEcCtD
Altretamine—Asthenia—Prednisone—hematologic cancer	2.51e-05	0.000258	CcSEcCtD
Altretamine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.48e-05	0.000254	CcSEcCtD
Altretamine—Anorexia—Doxorubicin—hematologic cancer	2.42e-05	0.000248	CcSEcCtD
Altretamine—Nausea—Betamethasone—hematologic cancer	2.39e-05	0.000245	CcSEcCtD
Altretamine—Nausea—Dexamethasone—hematologic cancer	2.39e-05	0.000245	CcSEcCtD
Altretamine—Decreased appetite—Epirubicin—hematologic cancer	2.38e-05	0.000244	CcSEcCtD
Altretamine—Fatigue—Epirubicin—hematologic cancer	2.36e-05	0.000242	CcSEcCtD
Altretamine—Dizziness—Prednisone—hematologic cancer	2.32e-05	0.000237	CcSEcCtD
Altretamine—Vomiting—Prednisone—hematologic cancer	2.23e-05	0.000228	CcSEcCtD
Altretamine—Decreased appetite—Doxorubicin—hematologic cancer	2.2e-05	0.000226	CcSEcCtD
Altretamine—Fatigue—Doxorubicin—hematologic cancer	2.19e-05	0.000224	CcSEcCtD
Altretamine—Asthenia—Methotrexate—hematologic cancer	2.1e-05	0.000215	CcSEcCtD
Altretamine—Nausea—Prednisone—hematologic cancer	2.08e-05	0.000213	CcSEcCtD
Altretamine—Asthenia—Epirubicin—hematologic cancer	1.97e-05	0.000202	CcSEcCtD
Altretamine—Dizziness—Methotrexate—hematologic cancer	1.94e-05	0.000198	CcSEcCtD
Altretamine—Vomiting—Methotrexate—hematologic cancer	1.86e-05	0.000191	CcSEcCtD
Altretamine—Asthenia—Doxorubicin—hematologic cancer	1.82e-05	0.000186	CcSEcCtD
Altretamine—Dizziness—Epirubicin—hematologic cancer	1.81e-05	0.000186	CcSEcCtD
Altretamine—Vomiting—Epirubicin—hematologic cancer	1.74e-05	0.000179	CcSEcCtD
Altretamine—Nausea—Methotrexate—hematologic cancer	1.74e-05	0.000178	CcSEcCtD
Altretamine—Dizziness—Doxorubicin—hematologic cancer	1.68e-05	0.000172	CcSEcCtD
Altretamine—Nausea—Epirubicin—hematologic cancer	1.63e-05	0.000167	CcSEcCtD
Altretamine—Vomiting—Doxorubicin—hematologic cancer	1.61e-05	0.000165	CcSEcCtD
Altretamine—Nausea—Doxorubicin—hematologic cancer	1.51e-05	0.000154	CcSEcCtD
